Trial intelligence / Profile preview

Study 038 versus controlled-release oxycodone in chronic non-cancer pain

ISRCTN76170309Phase 3Completed

Sponsor
Purdue Pharma
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of OxyContin ER, sponsored by Purdue Pharma. Started Jul 2008; status: completed.

02

Drugs

OxyContin ER

Beyond the preview

Go deeper on ISRCTN76170309.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN76170309.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call